NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma

<div>CBioPortal database analysis of the mutation of NMU and its interacted genes. (a) A visual summary of genetic alterations shows the genetic alteration of NMU and its interacted genes. (b) The particular mutations (G45V, R143T, and F152L) of NMU in LUAD patients. (c) Overall survival Kaplan-Meier estimate. (d) Progression-free survival Kaplan-Meier estimate.</div>

Disease Markers

fig5

Figure 5

Figure 5: NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma 